Skip to main content
. 2023 May 23;14:1195149. doi: 10.3389/fendo.2023.1195149

Figure 7.

Figure 7

Molecular docking of hub targets and active components of YNJ. (A) Nrf2-Stigmasterol; (B) SIRT1-Diosgenin; (C) Nrf2-Diosgenin; (D) NQO1-Diosgenin; (E) SIRT1-Baicalein; (F) NQO1-Baiclein; (G) SIRT1-Epiberberine; (H) NQO1-Epiberberine; (I) SIRT1-Palmatine; (J) Nrf2-Palmatine.